Mediastinal and subcutaneous chest fat are differentially associated with emphysema progression and clinical outcomes in smokers
Respiration Sep 24, 2017
Grace J, et al. - Obesity exerts both positive and negative impacts on clinical outcomes in chronic obstructive pulmonary disease (COPD). In this current study, researchers investigated if fat location explains the differential association of body mass index (BMI) with clinical outcome measures in smokers. They observed an association between increased subcutaneous chest fat and less emphysema progression over time in smokers. At the same time, they also reported an association of increased mediastinal fat volume with decreased walk distance and increased interleukin-6 (IL-6) levels.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries